Clinical Trial: Performance of Clinical Metagenomics in Stool and Urine Samples for Unexplained Diseases Diagnostic and Emerging Diseases Surveillance in Immunocompromised Patients

U.S., May 23 -- ClinicalTrials.gov registry received information related to the study (NCT07603453) titled 'Performance of Clinical Metagenomics in Stool and Urine Samples for Unexplained Diseases Diagnostic and Emerging Diseases Surveillance in Immunocompromised Patients' on May 18.

Brief Summary: The study is based on the hypothesis that the concomitant use of mNGS in non-invasive samples (stool, urine) could improve the rate of detected pathogens in immunodeficient patients compared with mNGS performed in an invasive reference sample alone (blood, CSF, broncho-alveolar lavage fluid (BAL), tissue).

Study Start Date: June 01

Study Type: OBSERVATIONAL

Condition: Primary or Secondary Immune Deficiency Including Immunosuppressive Therapy...